David Miller has successfully combined leadership roles in both business and research capacities. He has been a member of five early stage biotech companies, each of which has successfully transitioned to a public company. Currently, he is Senior Vice President, Corporate Operations at Dicerna Pharmaceuticals, Cambridge, MA, where he has been the past eight years. At Dicerna, he has also occupied the roles of Vice President of Research Operations and of Business Development. Dr. Miller was Senior Director, Business Development at Synta Pharmaceuticals, where he had partnering responsibility for their oncology portfolio and played a lead role in a pharma partnership, valued at over $1 billion. Prior to this, he was Director, Business Development at Altus Biologics where his responsibilities included developing their drug delivery business and the partnering of several biological products. Dr. Miller was a founder and the head of research for EcoScience Corporation, one of the first agricultural biotechnology companies developing biopesticides. He began his career at Genetics Institute. Dr. Miller is the inventor on six issued United States patents. He is a board member of EcoPesticides International, a New Mexico company, and on several public boards in his hometown of Winchester, MA.
Dr. Miller holds a Ph.D. in molecular biology and biochemistry from Harvard University and a B.S. in biochemistry and biophysics from the University of California, Davis.